IPO registrations (S-1, F-1) · Registrants
Immatics N.V.
- SEC CIK
- 1809196 · filings on EDGAR ↗
- Former names
- Immatics B.V. (2020–2020)
- Registration
- Form F-1, first filed 2020-07-31, last 2020-08-11; 1 initial registration, 1 amendment
- Outcome
- Declared effective 2020-08-13
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- P7
- Business address
- PAUL EHRLICH-STRASSE 15, Tubingen, 2M 72076
- Ticker
- IMTX (Nasdaq)
- EDGAR entity type
- other
- Insiders and CEO pay
- Immatics N.V. on the corporate pages
Offering terms
- Shares offered
- 52,493,617
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: Immatics N.V. EXACT (CIK (EXACT))
- Person page: Michael G Atieh Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 6
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2020-07-31 | F-1 | F-1 (foreign registration) | Immatics N.V. | 0001193125-20-206488 ↗ |
| 2020-08-11 | F-1/A | F-1/A (amendment) | Immatics N.V. | 0001193125-20-216438 ↗ |
| 2020-08-13 | EFFECT | EFFECT (declared effective) | Immatics N.V. | 9999999995-20-002137 ↗ |
| 2021-04-02 | EFFECT | EFFECT (declared effective) | Immatics N.V. | 9999999995-21-001264 ↗ |
| 2021-08-05 | EFFECT | EFFECT (declared effective) | Immatics N.V. | 9999999995-21-003055 ↗ |
| 2021-08-09 | EFFECT | EFFECT (declared effective) | Immatics N.V. | 9999999995-21-003115 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-08-11 | F-1/A | registration statement | 52,493,617 | - | 0 | primary document; shares headline | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Hothum Mathias | Director | 2 | 2026 | ||
| ATIEH MICHAEL G | Director | 2 | 2026 | person page Fuzzy | |
| Britten Cedrik Michael | Officer | Chief Medical Officer | 1 | 2026 | |
| Carter Paul Rutherford | Director | 2 | 2026 | ||
| Chambre Peter Alan | Director | 2 | 2026 | ||
| EDELMAN JOSEPH | Director | 2 | 2026 | ||
| Forster Eliot | Director | 2 | 2026 | ||
| Kramer Rainer | Officer | Chief Business Officer | 1 | 2026 | |
| Krause Amie Elizabeth | Officer | Chief People Officer | 1 | 2026 | |
| Mason Heather L | Director | 2 | 2026 | ||
| PERCEPTIVE ADVISORS LLC | Director | 3 | 2026 | ||
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | Director | 2 | 2026 | ||
| Ramanan Venkat | Officer | Chief Financial Officer | 1 | 2026 | |
| REICIN ALISE | Director | 2 | 2026 | ||
| Reinhardt Carsten Alexander Johannes | Officer | Chief Development Officer | 1 | 2026 | |
| Silverstein Jordan Zeik | Officer | Head of Strategy | 1 | 2026 | |
| Singh Jasuja Harpreet | Director,Officer | Chief Executive Officer | 1 | 2026 | |
| Stone Adam Leo | Director | 2 | 2026 | ||
| Sturchio Edward A Jr | Officer | General Counsel | 1 | 2026 | |
| Walter Steffen Martin | Officer | Chief Operating Officer | 1 | 2026 | |
| Weinschenk Toni Michael | Officer | Chief Innovation Officer | 1 | 2026 | |
| Pepin James Nelson | Officer | Gen Counsel and Corp Secretary | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | Immatics N.V. | SEC filers (EDGAR) | CIK (EXACT) | |
| Person page | Michael G Atieh | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), 2M first:
- BioNTech SE 2M
- CHEMOKINE THERAPEUTICS CORP A1
- Fusion Pharmaceuticals Inc. A6
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. AZ
- GENETIC TECHNOLOGIES LTD C3
- MESOBLAST LTD C3
- Ablynx NV C9
- SANGAMO THERAPEUTICS, INC CA
- GENITOPE CORP CA
- ABGENIX INC CA
In other datasets, the same topic (Health) in 2M:
- Form D issuer: ATAI Life Sciences AG (Form D private offerings)
Interests: Biological Products, (No Diagnostic Substances) · Health